Polypharmacy and potentially inappropriate medication use is highly prevalent in multiple myeloma patients and is improved by a collaborative physician-pharmacist clinic.

Karen I SweissGregory S CalipScott WirthDamiano RondelliPritesh Patel

Published in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2019)

Multiple myeloma patients have a high rate of polypharmacy but comanagement with a pharmacist reduced the number of all medications, but in particular the number of non-myeloma-related medications.

Keyphrases

multiple myeloma
end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
peritoneal dialysis
primary care
emergency department
prognostic factors
patient reported outcomes